Patents by Inventor Shannon E. Smith

Shannon E. Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Blocking IL-9 signaling in conjunction with chemotherapy to treat cancer
    Patent number: 10166292
    Abstract: This document provides methods and materials related to using inhibitors of IL-9 signaling in conjunction with chemotherapy to treat cancer (e.g., solid tumors). For example, methods and materials for using inhibitors of IL-9 signaling (e.g., anti-IL9 antibody preparations) in conjunction with chemotherapy to treat cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) or to reduce the growth rate of cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) within a mammal are provided.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: January 1, 2019
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Dominique B. Hoelzinger, Sandra J. Gendler, Peter A. Cohen, Ana L. Dominguez, Shannon E. Smith, Joseph Lustgarten
  • BLOCKING IL-9 SIGNALING IN CONJUNCTION WITH CHEMOTHERAPY TO TREAT CANCER
    Publication number: 20180153994
    Abstract: This document provides methods and materials related to using inhibitors of IL-9 signaling in conjunction with chemotherapy to treat cancer (e.g., solid tumors). For example, methods and materials for using inhibitors of IL-9 signaling (e.g., anti-IL9 antibody preparations) in conjunction with chemotherapy to treat cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) or to reduce the growth rate of cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) within a mammal are provided.
    Type: Application
    Filed: October 30, 2017
    Publication date: June 7, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Dominique B. Hoelzinger, Sandra J. Gendler, Peter A. Cohen, Ana L. Dominguez, Shannon E. Smith, Joseph Lustgarten
  • Blocking IL-9 signaling in conjunction with chemotherapy to treat cancer
    Patent number: 9833512
    Abstract: This document provides methods and materials related to using inhibitors of IL-9 signaling in conjunction with chemotherapy to treat cancer (e.g., solid tumors). For example, methods and materials for using inhibitors of IL-9 signaling (e.g., anti-IL9 antibody preparations) in conjunction with chemotherapy to treat cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) or to reduce the growth rate of cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) within a mammal are provided.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: December 5, 2017
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Dominique B. Hoelzinger, Sandra J. Gendler, Peter A. Cohen, Ana L. Dominguez, Shannon E. Smith, Joseph Lustgarten
  • BLOCKING IL-9 SIGNALING IN CONJUNCTION WITH CHEMOTHERAPY TO TREAT CANCER
    Publication number: 20150343057
    Abstract: This document provides methods and materials related to using inhibitors of IL-9 signaling in conjunction with chemotherapy to treat cancer (e.g., solid tumors). For example, methods and materials for using inhibitors of IL-9 signaling (e.g., anti-IL9 antibody preparations) in conjunction with chemotherapy to treat cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) or to reduce the growth rate of cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) within a mammal are provided.
    Type: Application
    Filed: April 9, 2015
    Publication date: December 3, 2015
    Inventors: Dominique B. Hoelzinger, Sandra J. Gendler, Peter A. Cohen, Ana L. Dominguez, Shannon E. Smith, Joseph Lustgarten